We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MR Techniques Find Link Between NAFLD and Heart Failure in Obese People

By HospiMedica International staff writers
Posted on 26 Jan 2016
The results of a new study published online in the journal Radiology, has found that fatty liver is independently associated with subclinical heart failure in people who are obese.

Non-Alcoholic Fatty Liver Disease (NAFLD) occurs when large droplets of fat are deposited in the liver (hepatic steatosis). More...
The disease is related to insulin resistance, and includes risk factors such as obesity and diabetes. The disease is common in children in the United States and the Western World and can lead to hepatitis, cirrhosis, scars in liver tissue, and liver cancer. Up to 30% of the general population in the US suffer from NAFLD. The prevalence of NAFLD in obese people or people suffering from type 2 diabetes is between 70% to 90%. NAFLD is a manifestation of risk factors such as high blood pressure, unhealthy cholesterol levels, and excess abdominal fat that increase the risk of strokes, heart attacks, and diseases.

The researchers from the Leiden University Medical Center, (LUMC; Leiden, The Netherlands) studied 714 men and women aged between 45 and 65 years, 47% of which were classified as overweight, and 13% as obese. The researchers used proton Magnetic Resonance Spectroscopy (MRS) to measure hepatic triglyceride content, noninvasively, and cardiac Magnetic Resonance Imaging (MRI) to assess left ventricular diastolic function.

Lead author of the study, Ralph L. Widya, MD, said, “One of the unique aspects of our study is that we took all of the individual components of the metabolic syndrome into account as possible confounders in this association, as the metabolic syndrome is associated with NAFLD and with cardiovascular disease. Our results may be of importance in cardiovascular risk stratification in obesity, because there is a large variation in the degree of hepatic steatosis in obesity. Also, more emphasis should be put on dietary interventions to reduce or prevent hepatic steatosis. The reasons for the link between fatty liver and heart function are unknown, but could be related to several factors, including the presence of infection-fighting white bloods cells called macrophages or increased expression in the liver of small proteins known as cytokines. Future research is required to study the effect of NAFLD on cardiovascular events, and further study is needed to investigate to what extent the association exists and differs among normal weight, overweight and obese persons”.

Related Links:

Leiden University Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Syringe Pump
SP50 Series
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.